EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS

被引:0
|
作者
Portolese, Olivia [1 ]
Bilodeau, Marc [2 ]
Castel, Helene [1 ]
Willems, Bernard E. [1 ]
Huard, Genevieve [1 ]
Vincent, Catherine [2 ]
Lavoie, Annick [1 ]
Hercun, Julian [1 ]
机构
[1] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1708-A
引用
收藏
页码:S638 / S639
页数:2
相关论文
共 50 条
  • [1] Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis
    Tewkesbury, Daniel H.
    Scott, Jennifer
    Barry, Peter J.
    Bright-Thomas, Rowland J.
    Hanley, Karen Piper
    Athwal, Varinder
    Jones, Andrew M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 349 - 353
  • [2] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
  • [3] Effects of elexacaftor-tezacaftor-ivacaftor discontinuation in cystic fibrosis
    Mitropoulou, Georgia
    Balmpouzis, Zisis
    Polojoux, Jerome
    Dotta-Celio, Jennifer
    Sauty, Alain
    Koutsokera, Angela
    RESPIRATORY MEDICINE AND RESEARCH, 2022, 82
  • [4] Characterization of sleep in emerging adults with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor
    Meltzer, Lisa J.
    Gross, Jane E.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 132 - 136
  • [5] The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis
    Scully, Kevin J.
    Marchetti, Peter
    Sawicki, Gregory S.
    Uluer, Ahmet
    Cernadas, Manuela
    Cagnina, Rebecca E.
    Kennedy, John C.
    Putman, Melissa S.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : 258 - 263
  • [6] Incidence of transaminitis in adults with cystic fibrosis taking elexacaftor/tezacaftor/ivacaftor
    Wood, Marci
    Babowicz, Faith
    Kennedy, Amanda G.
    Antell, Martine
    Gilhooly, Elizabeth
    Tompkins, Bradley J.
    Reddy, Sheela S.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (03) : 920 - 924
  • [7] Safety and effectiveness of treatment with elexacaftor, tezacaftor and ivacaftor in adults with cystic fibrosis
    Royo, Rosa Nieto
    Barata, Diego Duran
    Barreto, Deisy Barrios
    Franquiz, Winnifer Briceno
    Carro, Luis Maiz
    MEDICINA CLINICA, 2023, 161 (08): : 338 - 341
  • [8] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
    Lorenz, Judith
    PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
  • [9] Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis
    McKinzie, Cameron J.
    Doligalski, Christina T.
    Lobritto, Steven J.
    Coakley, Raymond D.
    Gower, W. Adam
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : 227 - 229
  • [10] Tolerance of elexacaftor/tezacaftor/ivacaftor in Australians with cystic fibrosis
    Ruseckaite, Rasa
    Wark, Peter
    Pourghaderi, Ahmadreza
    Caruso, Marisa
    Ahern, Susannah
    RESPIROLOGY, 2024, 29 : 8 - 8